Progressing Regenerative Medicine: Integrating Bioprinting Platforms for Stem Cell Applications

Advancements in regenerative medicine are increasingly driven by the convergence of stem cell biology and bioprinting technologies. Stem cells have the potential to be used to engineer functional tissues and organs because of their innate ability to self-renew and differentiate. But conventional methods that use xenografts and decellularized scaffolds have issues with biocompatibility and architectural complexity. This review critically evaluates bioprinting strategies tailored for stem cell applications, including the selection of stem cell sources, bioink formulation, crosslinking methodologies, and dynamic culture systems. Particular focus is given to ensuring cell viability, lineage-specific differentiation, and functional integration post-fabrication. The review also highlights recent advancements in printing complex tissues such as skin, neural, cardiac, hepatic, and musculoskeletal constructs using embryonic, adult, and induced pluripotent stem cells (iPSCs). Current challenges, ranging from bioink standardization to vascularization, are addressed alongside emerging innovations like microfluidic printing and gene-activated matrices. By evaluating the integration of bioprinting with stem cell technologies, this article underscores their synergistic potential to address critical gaps in tissue engineering and lays the foundation for translational applications in clinical and pharmaceutical domains.